Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

359.02 +1.91 (+0.53%)
Streaming Delayed Price Updated: 11:37 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know
Via Benzinga
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength. 
Via Benzinga
Topics ETFs
Top Analyst Reports For Bank Of America, Chevron & Stryker
Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation, Chevron Corporation, and Stryker Corporation, as well as two micro-cap stocks, Value... 
Via Talk Markets
Topics Stocks / Equities
Here's How Much $100 Invested In Stryker 15 Years Ago Would Be Worth Today
Via Benzinga
Meritage Homes, TopBuild, Installed Building Products, Champion Homes, and Stryker Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
What Does the Market Think About Stryker?
Via Benzinga
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?
Although Stryker has dropped 5.3% to $335.22 per share over the past six months, it has beaten the S&P 500 by 8.6 percentage points. 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
Stryker to announce financial results for its first quarter of fiscal year 2025
From Stryker Corporation
Via GlobeNewswire
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. 
Via StockStory
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
From VB Spine, LLC
Via GlobeNewswire
Stryker completes sale of U.S. spinal implants business
From Stryker Corporation
Via GlobeNewswire
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
Exposures Political
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock
Via Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Stryker announces intention to nominate Manny Maceda to board of directors
From Stryker Corporation
Via GlobeNewswire
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
Here's How Much $1000 Invested In Stryker 5 Years Ago Would Be Worth Today
Via Benzinga
What's Driving the Market Sentiment Around Stryker?
Via Benzinga
Breaking Down Stryker: 13 Analysts Share Their Views
Via Benzinga
New Jersey Rep. Thomas Kean Sold Over $17K Worth of Stryker Stock: Here's What You Should Know
Via Benzinga
Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers. 
Via StockStory
1 Large-Cap Stock with Solid Fundamentals and 2 to Avoid
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
If You Could Only Hold 3 Investments for Life, Consider These
Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth. 
Via MarketBeat
Topics ETFs Economy Retirement
Exposures Economy Pension
3 Growth Stocks to Buy and Hold Forever
Via The Motley Fool
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified... 
Via StockStory
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - diversified stocks fared in Q4,... 
Via StockStory
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers. 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.